Evidence map›Paper›PMID 8973564›Full record

ArticleThe Biochemical journal1996

Identification of phosphorylation sites in keratinocyte transglutaminase.

R H Rice, M Mehrpouyan, Q Quin, M A Phillips, Y M Lee

Open access · bronzeAbstract read
In one paragraph

Article in The Biochemical journal, 1996. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 8 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

R H RiceDepartment of Environmental Toxicology, University of California, Davis, CA 95616-8588, USA.
M Mehrpouyan
Q Quin
M A Phillips
Y M Lee
University of California, Davis · US

Funding

Workshop on Environmental Technology Transfer and EntrepreneurshipP42ES004699 · NIEHS · UNIVERSITY OF CALIFORNIA DAVIS · PI HAMMOCK, BRUCE D · 1987 to 2021
$50.1M
KERATINOCYTE TRANSGLUTAMINASE--STRUCTURE AND REGULATIONR01AR027130 · NIAMS · UNIVERSITY OF CALIFORNIA DAVIS · PI RICE, ROBERT H · 1986 to 2004
$1.0M
NIAMS NIH HHS AR27130NIEHS NIH HHS ES04699NIEHS NIH HHS ES05707
6 · The paper itself

Abstract

Phosphorylation of keratinocyte transglutaminase occurs in its N-terminal extension and is stimulated several-fold by the protein kinase C agonist phorbol myristate acetate. In the present work, this stimulation was prevented by simultaneous treatment of the cells with the protein kinase C-selective inhibitor GF109203X. In contrast, phosphorylation occurring in the absence of phorbol ester was essentially unaffected by GF109203X, although it was decreased dramatically by the non-selective kinase inhibitor staurosporine. Four serine residues that are subject to phosphorylation have been identified by sequencing of radioactive tryptic peptides. Serines at positions 24 and 92, each containing 2-8% of the total radioactivity with or without phorbol ester stimulation, were minor sites of phosphorylation. Serine-82 was by far the dominant site of phosphorylation in the absence of phorbol ester treatment, and was also the major site in its presence. Serine-85 was phosphorylated to a high degree in the presence but not in the absence of phorbol ester stimulation. Thus the data indicate the influence of at least two different kinase activities in transglutaminase phosphorylation.

Indexed as

3T3 CellsAmino Acid SequenceAnimalsCells, CulturedChromatography, High Pressure LiquidHumansKeratinocytesMiceMolecular Sequence DataPeptide FragmentsPeptide MappingPhosphopeptidesPhosphoproteinsPhosphorylationSkinTransglutaminasesPeptide FragmentsPhosphopeptidesPhosphoproteinsTransglutaminasesTrypsin

Identifiers

PMID8973564
PMCPMC1217963
OpenAlexW2226253281

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.